How severe is CVE-2017-17674?

CVE-2017-17674 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2017-17674 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (83rd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2017-17674?

CVE-2017-17674 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2017-17674?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2017-17674 published?

CVE-2017-17674 was published on 2021-05-19 and last updated on 2026-07-05.

CVE-2017-17674

CVE-2017-17674 is a critical-severity vulnerability in Bmc Remedy Mid-tier with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-918.

Key facts

Severity: Critical (CVSS 3.x base score 9.8)
CVSS v2: 7.5
EPSS exploit prediction: 3% (83rd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-918
Affected product: Bmc Remedy Mid-tier
Published: 2021-05-19
Last modified: 2026-07-05

Description

BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE).

Frequently asked questions

What is CVE-2017-17674?: BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE).
How severe is CVE-2017-17674?: CVE-2017-17674 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2017-17674 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (83rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-17674?: CVE-2017-17674 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2017-17674?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2017-17674 published?: CVE-2017-17674 was published on 2021-05-19 and last updated on 2026-07-05.

References

Affected products (1)

cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*

More vulnerabilities in Bmc Remedy Mid-tier

CVE-2024-34399 — Critical (CVSS 9.8): **UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. An unauthenticated remote attacker…
CVE-2017-17677 — High (CVSS 8.8): BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create…
CVE-2018-18862 — High (CVSS 8.8): BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as…
CVE-2017-17678 — Medium (CVSS 6.1): BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability…
CVE-2017-17675 — Medium (CVSS 5.3): BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users,…
CVE-2024-34398 — Medium (CVSS 4.2): An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by…

All CVEs affecting Bmc Remedy Mid-tier →

Other CWE-918 (Server-Side Request Forgery (SSRF)) vulnerabilities

CVE-2026-47938 — Critical (CVSS 10.0): Adobe Campaign Classic (ACC) versions 7.4.3 build 9394 and earlier are affected by a Server-Side Request Forgery (SSRF)…
CVE-2026-35431 — Critical (CVSS 10.0): Server-side request forgery (ssrf) in Microsoft Entra ID Entitlement Management allows an unauthorized attacker to…
CVE-2026-32186 — Critical (CVSS 10.0): Server-side request forgery (ssrf) in Microsoft Bing allows an unauthorized attacker to elevate privileges over a…
CVE-2026-33107 — Critical (CVSS 10.0): Server-side request forgery (ssrf) in Azure Databricks allows an unauthorized attacker to elevate privileges over a…
CVE-2026-32871 — Critical (CVSS 10.0): FastMCP is a Pythonic way to build MCP servers and clients. Prior to version 3.2.0, the OpenAPIProvider in FastMCP…
CVE-2026-32169 — Critical (CVSS 10.0): Server-side request forgery (ssrf) in Azure Cloud Shell allows an unauthorized attacker to elevate privileges over a…

Browse all CWE-918 (Server-Side Request Forgery (SSRF)) vulnerabilities →